HBK Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,760
Closed -$624K 256
2023
Q2
$624K Buy
+9,760
New +$654K ﹤0.01% 315
2022
Q3
Sell
-3,677
Closed -$267K 438
2022
Q2
$283K Sell
3,677
-13,221
-78% -$1.01M ﹤0.01% 465
2022
Q1
$1.23M Buy
+16,898
New +$1.13M 0.01% 444
2021
Q1
Sell
-95,834
Closed -$5.96M 846
2020
Q4
$5.95M Buy
95,834
+28,372
+42% +$1.74M 0.04% 239
2020
Q3
$4.07M Sell
67,462
-6,381
-9% -$384K 0.03% 266
2020
Q2
$4.34M Buy
+73,843
New +$4.42M 0.06% 208
2019
Q2
Sell
-659,466
Closed -$30.7M 654
2019
Q1
$31.5M Buy
659,466
+389,302
+144% +$19.4M 0.32% 46
2018
Q4
$14M Buy
270,164
+67,041
+33% +$3.6M 0.15% 104
2018
Q3
$12.6M Sell
203,123
-490,134
-71% -$29.1M 0.1% 120
2018
Q2
$38.4M Buy
693,257
+415,802
+150% +$22.5M 0.25% 41
2018
Q1
$17.5M Buy
277,455
+176,755
+176% +$11.4M 0.12% 92
2017
Q4
$6.17M Buy
+100,700
New +$6.3M 0.05% 229
2017
Q3
Sell
-23,601
Closed -$1.31M 1018
2017
Q2
$1.31M Buy
+23,601
New +$1.28M 0.01% 509
2016
Q3
Sell
-7,056
Closed -$519K 837
2016
Q2
$519K Buy
+7,056
New +$499K ﹤0.01% 719
2015
Q2
Sell
-24,000
Closed -$1.55M 942
2015
Q1
$1.55M Buy
+24,000
New +$1.5M 0.01% 456
2014
Q3
Sell
-71,544
Closed -$3.47M 960
2014
Q2
$3.47M Buy
+71,544
New +$3.53M 0.07% 242

Other funds holding BMY

HBK Investments's BMY Position: Q3 2023 in Review

HBK Investments sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 9,760 shares — an estimated $624K sold.

HBK Investments first reported a position in BMY in Q2 2014 and held it in 16 quarters. The position peaked at $38.4M in Q2 2018. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • HBK Investments reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • HBK Investments sold 9,760 Bristol-Myers Squibb shares in Q3 2023, an estimated $624K.
  • HBK Investments first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 16 quarters.
  • HBK Investments's Bristol-Myers Squibb position peaked at $38.4M in Q2 2018.
  • 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.